| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
PD1Neoplasia (Tumor biology and immunology)Costimulation (T Cell)| 1 | 2007 | PD-1 and PD-1 ligands: from discovery to clinical application. | 
| + | - | nl | Int Immunol 19(7):813-24 (2007) |
| 2 | 2002 | The role of novel T cell costimulatory pathways in autoimmunity and transplantation. | 
| + | - | nl | J Am Soc Nephrol 13(2):559-75 (2002) |
| 3 | 2007 | PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. |
| + | - | nl | Clin Cancer Res 13(6):1757-61 (2007) |
| 4 | 2010 | Tumor progression by immune evasion in melanoma: role of the programmed cell death-1/programmed cell death-1 ligand 1 interaction. |
| + | - | nl | Cancer 116(7):1623-5 (2010) Kashani-Sabet M |
| 5 | 2011 | An essential role for programmed death-1 in the control of autoimmunity: implications for the future of hematopoietic stem cell transplantation. |
| + | - | nl | Future Oncol 7(8):929-32 (2011) |
| 6 | 2010 | Role of PD-1 in regulating acute infections. |
| + | - | nl | Curr Opin Immunol 22(3):397-401 (2010) |
| 7 | 2010 | Editorial: PD-1, a new target for sepsis treatment: better late than never. |
| + | - | nl | J Leukoc Biol 88(2):225-6 (2010) Goyert SM |
| 8 | 2010 | The PD-1 pathway in tolerance and autoimmunity. |
| + | - | nl | Immunol Rev 236(-):219-42 (2010) |
| 9 | 2009 | Fine tuning the immune response through B7-H3 and B7-H4. |
| + | - | nl | Immunol Rev 229(1):145-51 (2009) |
